| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Adjusted EBITDA for the full year 2025 is expected to be essentially flat with the prior year. Capital expenditures for the full year 2025 are expected to be in the range of $90 to $100 million (net of reimbursements).
Posted In: ATNI